LIBTAYO 350 mg concentrate for solution for infusion., Fianlimab
R3767-ONC-2466
Phase 2 small_molecule active
Quick answer
LIBTAYO 350 mg concentrate for solution for infusion., Fianlimab for Melanoma is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active